During the past decade, The Medical Group of Northern Nevada conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "The Medical Group of Northern Nevada" are "Fibrocystic Changes of Breast" (1 trials), "Fibrocystic Disease of Breast" (1 trials), "Fibrocystic Mastopathy" (1 trials), "Infertility" (1 trials) and "Pain" (1 trials). Many other conditions were trialed in "The Medical Group of Northern Nevada" in a lesser frequency.

Most popular intervention types in "The Medical Group of Northern Nevada" are "Drug" (3 trials). Other intervention types were less common.

The name of intervention was led by "GnRH iontophoretic transdermal Lutrepatch" (1 trials), "IoGen (molecular iodine)" (1 trials), "butoconazole nitrate" (1 trials), "clindamycin phosphate" (1 trials) and "clindamycin phosphate/butoconazole nitrate" (1 trials). Other intervention names were less common.

The vast majority of trials in "The Medical Group of Northern Nevada" are 3 trials for "Female" genders.

Currently, there are NaN active trials in "The Medical Group of Northern Nevada". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in The Medical Group of Northern Nevada, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in The Medical Group of Northern Nevada, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".